Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 3/20 | 0.41 |
| ▸ | LPL | P06858 | 2/20 | 0.41 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.35 |
| ▸ | KDR | P35968 | 1/20 | 0.35 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.33 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.33 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.32 |
| ▸ | IDO1 | P14902 | 1/20 | 0.31 |
| ▸ | TDO2 | P48775 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL352617 | 0.83 | LPL (0.40) | LIPGLPLPRMT5WDR77DGAT1 | |
| SCHEMBL17177947 | 0.69 | LIPG (0.61) | LIPGLPLPDGFRBKDRPRMT5 | |
| SCHEMBL12390740 | 0.67 | LIPG (0.56) | LIPGLPLPDGFRBKDRPRMT5 | |
| SCHEMBL12999308 | 0.67 | LIPG (0.56) | LIPGLPLPDGFRBKDRPRMT5 | |
| SCHEMBL4907823 | 0.67 | LIPG (0.71) | LIPGLPLPDGFRBKDRDGAT1 | |
| SCHEMBL16788914 | 0.67 | LIPG (0.62) | LIPGLPLPDGFRBKDRPRMT5 | |
| SCHEMBL18544783 | 0.67 | LIPG (0.50) | LIPGLPLPDGFRBKDRPRMT5 | |
| SCHEMBL13237477 | 0.67 | LPL (0.40) | LIPGLPLPRMT5WDR77 | |
| SCHEMBL26048046 | 0.66 | LIPG (0.61) | LIPGLPLPDGFRBKDRDGAT1 | |
| SCHEMBL18542430 | 0.66 | LIPG (0.49) | LIPGLPLPDGFRBKDRPRMT5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2409974-B1 | COMPOUND HAVING BENZOTRIAZOLE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENT ELEMENT | HODOGAYA CHEMICAL CO LTD (JP) | 2018-04-25 | — | — | EP | disclosed |
| US-9005776-B2 | Compound having benzotriazole ring structure and organic electroluminescent element | HODOGAYA CHEMICAL CO., LTD. (JP) | 2015-04-14 | — | — | US | disclosed |
| EP-2409974-A1 | COMPOUND HAVING BENZOTRIAZOLE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENT ELEMENT | Hodogaya Chemical Co., Ltd. (JP) | 2012-01-25 | — | — | EP | disclosed |
| US-20120012831-A1 | COMPOUND HAVING BENZOTRIAZOLE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENT ELEMENT | SHINSHU UNIVERSITY (JP) | 2012-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120012831-A1 | COMPOUND HAVING BENZOTRIAZOLE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENT ELEMENT | BRD4, ARNT, MLLT1 | LIPG 4699/4885LPL 4287/4885PDGFRB 1664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.